A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
doi: 10.1111/dom.14572 24 Common Terminology Criteria for Adverse Events (CTCAE) v6.0 (MedDRA 28.0) (Bethesda, MD, USA: National Cancer Institute, National Institutes of Health)
The weight regain reality Clinical trial data is clear: most people regain a significant portion of lost weight after discontinuing GLP-1 therapy
Potential contributors may include baseline reward sensitivity, emotional eating tendency, metabolic status, diabetes status, medication adherence, gastrointestinal tolerability, prior dietary patterns, and broader psychological context, but these variables have not yet been systematically integrated
Finally, some amino acids that come from the breakdown of dietary proteins may bind to receptors that stimulate GLP-1 secretion
The elevated cAMP activates two primary pathways: Protein Kinase A (PKA) and Exchange Protein directly Activated by cAMP (EPAC)
